Psilocybin: CBD 2.0 or Something New?

Psilocybin: CBD 2.0 or Something New?

14th March 2024

Psilocybin. You might know about this psychedelic compound through the name ‘magic mushrooms’, ‘shrooms’ or ‘caps’. But recent scientific discoveries, and changing legislations, have set psilocybin on a journey from recreation, to lifestyle, to medicalization and potential commercialization.

This report focuses on the evolving attitudes and perceptions around psilocybin as changing landscapes around regulatory and legal frameworks and cultural acceptance move the substance into this new era. To arrive at these insights, we partnered on this report with ConcentricLife, a healthcare agency with a focus on wellness and innovative healthcare practices. 

We explore Psilocybin over 20 pages, 22 data visualizations, and over 13M datapoints across X (formerly Twitter), Facebook, Reddit, Instagram, TikTok, Tumblr, Online News, Blogs and more.

Psilocybin conditions alluvial showing associated conditions

This report unpacks: 

  • The difference in conversation when we look through the lens of medicalization, legalization and recreation & wellness
  • Spotlights on geographical differences, bodily experiences and associated substances
  • Which audiences are talking about psilocybin and how they relate differently to psilocybin 
  • The conditions most associated with psilocybin
  • How psilocybin’s journey differs to that of CBD & THC
  • What the pharmaceutical and commercial future of psilocybin looks like
  • Where chocolate comes into the equation

 

To access these insights, simply fill in the form below:

 


Spotlight